FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lori Zuk

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Duodenal Ulcer

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Alan B R Thomson; Monika Keelan; Rosann Lastiwka; S Appelman-Eszczuk; Lori Zuk; Laurie A Drozdowski; A Prentice; Paul Sinclair
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
Alan B R Thomson; Monika Keelan; Rosann Lastiwka; Sharon Appelman-Eszcuck; Lori Zuk; Laurie A Drozdowski; Anne Prentice; Paul Sinclair
Acid inhibitory potency of twice a day omeprazole is not affected by eradication of Helicobacter pylori in healthy volunteers.
Alan B R Thomson; P Kirdeikis; Lori Zuk
Comparison of 200 mg cimetidine with multiple doses of antacid on extent and duration of rise in gastric pH in volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lori Zuk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Alan B R Thomson; Monika Keelan; Rosann Lastiwka; S Appelman-Eszczuk; Lori Zuk; Laurie A Drozdowski; A Prentice; Paul Sinclair
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
Digestive diseases and sciences 2003;48(10):2045-56.
2003: Alan B R Thomson; Monika Keelan; Rosann Lastiwka; Sharon Appelman-Eszcuck; Lori Zuk; Laurie A Drozdowski; Anne Prentice; Paul Sinclair
Acid inhibitory potency of twice a day omeprazole is not affected by eradication of Helicobacter pylori in healthy volunteers.
Helicobacter 2003;8(1):46-58.
1999: Alan B R Thomson; P Kirdeikis; Lori Zuk
Comparison of 200 mg cimetidine with multiple doses of antacid on extent and duration of rise in gastric pH in volunteers.
Digestive diseases and sciences 1999;44(10):2051-5.
1999: Alan B R Thomson; P Kirdeikis; Rosann Lastiwka; Lori Zuk; M Jen; M Elias; P Johnston
Food but not a chemically defined diet interferes with maintenance of intragastric pH at a predefined level using continuous pH-stat-adjusted intravenous infusion of ranitidine in healthy volunteers.
Digestive diseases and sciences 1999;44(9):1858-64.
1996: Alan B R Thomson; Varocha Mahachai; Robert J Bailey; P Kirdeikis; Lori Zuk; Barbara J Marriage; I Simpson; Fakhreddin Jamali
Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
Journal of gastroenterology and hepatology 1996;11(12):1171-6.
1995: Fakhreddin Jamali; Alan B R Thomson; P Kirdeikis; Michele M Tavernini; Lori Zuk; Barbara J Marriage; I Simpson; Varocha Mahachai
Diurnal variation in the pharmacokinetics of nizatidine in healthy volunteers and in patients with peptic ulcer disease.
Journal of clinical pharmacology 1995;35(11):1071-5.
1995: A Thompson; P Kirdeikis; Fakhreddin Jamali; Michele M Tavernini; Lori Zuk; Barbara J Marriage; I Simpson; Varocha Mahachai
Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E2 and serum gastrin concentrations in healthy volunteers.
Journal of gastroenterology and hepatology 1995;10(5):546-54.
1994: Alan B R Thomson; L Babiuk; P Kirdeikis; Lori Zuk; Barbara J Marriage; Kenneth L Bowes
A dose-ranging study of ranitidine and its effect on intragastric and intra-oesophageal acidity in subjects with gastro-oesophageal reflux disease.
Alimentary pharmacology & therapeutics 1994;8(4):443-51.
1993: Alan B R Thomson; P Kirdeikis; K Simon; Lori Zuk; B Pinchbeck; D Wasarab-Rolland; K Kersey
Effect of intravenous infusion of ranitidine on intragastric acidity in fasting subjects: comparison with bolus or Gastrojet (pH-stat-adjusted) infusion.
Alimentary pharmacology & therapeutics 1993;7(6):649-53.
1992: C Cederberg; Alan B R Thomson; Varocha Mahachai; J A Westin; P Kirdeikis; D Fisher; Lori Zuk; Barbara J Marriage
Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients.
Gastroenterology 1992;103(3):913-8.
1989: Alan B R Thomson; B R Pinchbeck; J Kirdeikis; Lori Zuk; Barbara J Marriage; A Prat
A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
Alimentary pharmacology & therapeutics 1989;3(2):199-210.
1988: Alan B R Thomson; H N McCullough; P Kirdeikis; Lori Zuk; I Simpson; D J Cook; R A Wildeman; K Brunet; D Fisher; B Pinchbeck
Twenty-four-hour intragastric measurements in twenty healthy subjects: effect of enisoprost, a novel and potent antisecretory and antipeptic synthetic E1 prostaglandin.
Alimentary pharmacology & therapeutics 1988;2(4):325-36.
1988: Alan B R Thomson; B Pinchbeck; J Kirdeikis; P Kirdeikis; Lori Zuk; M K Brunet; M Jurima-Romet; P E Murray
Evaluation of antacid tablets and liquid in fasting and fed men and women.
Clinical therapeutics 1988;10(2):158-68.
1987: L D Jewell; W Yacoub; M L Salkie; R Sherbaniuk; K Walker; Varocha Mahachai; P Kirdeikis; I Simpson; Lori Zuk; M K Brunet
Enprostil reduces G-cell hyperplasia and hypergastrinemia in duodenal ulcer.
Clinical therapeutics 1987;9(3):281-95.
1986: R Sherbaniuk; L D Jewell; W Yacoub; B Pinchbeck; M L Salkie; K Walker; Varocha Mahachai; P Kirdeikis; Lori Zuk; M K Brunet
Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma.
Clinical therapeutics 1986;8(6):667-88.
1985: Varocha Mahachai; K Walker; Alan B R Thomson; Lori Zuk; P Kirdeikis; D Fisher; K Brunet
Comparison of cimetidine and ranitidine on 24-hour intragastric acidity and serum gastrin profile in patients with esophagitis.
Digestive diseases and sciences 1985;30(4):321-8.
1985: K Walker; B Pinchbeck; Varocha Mahachai; I Simpson; P Kirdeikis; Lori Zuk; K Brunet; R Sherbaniuk; L Chitnuyanondh; R Cherry
Postprandial changes in serum concentrations of gastrin-17, gastrin-34, and total gastrin in patients with duodenal or gastric ulcers and in normal subjects.
Clinical therapeutics 1985;7(6):704-16.